Haiying Zhu
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
DJ-1 inhibition reshapes tumor microenvironment and potentiates immune checkpoint inhibitors.
Journal: Science advances
Published: April 08, 2026
A Prostate-Specific Membrane Antigen-Targeting Small Molecule-Drug Conjugate Strategy to Overcome the Hematological Toxicity of Olaparib.
Journal: Journal of medicinal chemistry
Published: November 01, 2024
Synthesis and structure-activity optimization of hydroxypyridinones against rhabdomyolysis-induced acute kidney injury.
Journal: European journal of medicinal chemistry
Published: September 26, 2023
Targeting Labile Iron-Mediated Ferroptosis Provides a Potential Therapeutic Strategy for Rhabdomyolysis-Induced Acute Kidney Injury.
Journal: ACS chemical biology
Published: May 12, 2023
The dichotomous role of immunoproteasome in cancer: Friend or foe?
Journal: Acta pharmaceutica Sinica. B
Published: June 03, 2022
WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit.
Journal: Acta pharmaceutica Sinica. B
Published: June 28, 2021
One therapeutic approach for triple-negative breast cancer: Checkpoint kinase 1 inhibitor AZD7762 combination with neoadjuvant carboplatin.
Journal: European journal of pharmacology
Published: March 10, 2021
PD-1/PD-L1 counterattack alliance: multiple strategies for treating triple-negative breast cancer.
Journal: Drug discovery today
Published: March 26, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026